BM Brucker, J King, PN Mudd Jr, K McHale - Current Therapeutic Research, 2022 - Elsevier
Background The β 3-adrenergic agonists vibegron and mirabegron have shown favorable
safety profiles and efficacy for the treatment of overactive bladder. However, β-adrenergic …